Loading…
The performance of Carbohydrate Antigen 125-Thomsen-nouveau and anti-Müllerian hormone combined with CA125, Human epididymis protein 4 and Risk of Malignancy Algorithm in diagnosis for patients with Epithelial ovarian cancer
Hou, Xiuzhu, Liu, Shanshan, Liu, Jing, Zhou, Jiansuo, Liang, Yongming, Cui, Liyan
Published in Clinical biochemistry (01.09.2023)
Published in Clinical biochemistry (01.09.2023)
Get full text
Journal Article
Loading…
Discriminative value of CA-125, HE4, Risk of Malignancy Index II (RMI-II) and Risk of Malignancy Algorithm (ROMA) in the differential diagnosis of pelvic masses: conclusions from a referral Centre in Portugal
Melo, Ângela, Veríssimo, Renata, Farinha, Margarida, Martins, Nuno Nogueira, Martins, Francisco Nogueira
Published in Journal of obstetrics and gynaecology (17.11.2018)
Published in Journal of obstetrics and gynaecology (17.11.2018)
Get more information
Journal Article
Loading…
Standard and optimal cut-off values of serum ca-125, HE4 and ROMA in preoperative prediction of ovarian cancer in Vietnam
Huy, Nguyen Vu Quoc, Van Khoa, Vo, Tam, Le Minh, Vinh, Truong Quang, Tung, Nguyen Sanh, Thanh, Cao Ngoc, Chuang, Linus
Published in Gynecologic oncology reports (01.08.2018)
Published in Gynecologic oncology reports (01.08.2018)
Get full text
Journal Article
Loading…
Costs, Effectiveness, and Workload Impact of Management Strategies for Women With an Adnexal Mass
Havrilesky, Laura J., Dinan, Michaela, Sfakianos, Gregory P., Curtis, Lesley H., Barnett, Jason C., Van Gorp, Toon, Myers, Evan R.
Published in JNCI : Journal of the National Cancer Institute (01.01.2015)
Published in JNCI : Journal of the National Cancer Institute (01.01.2015)
Get full text
Journal Article